The British cancer diagnostics company, Biofidelity Ltd, has named Wendy Levin as chief medical officer, based in the US. The appointment is part of an expansion of the company’s executive team following a recent Series A financing. Dr Levin is an oncologist and haematologist with over 15 years of experience in biotech. She began her undergraduate and graduate career at the University of California, Los Angeles, US, where she co-authored the first publications on HER-2/neu in breast and ovarian cancers.
Biofidelity announced the appointment on 28 January 2021
Copyright 2021 Evernow Publishing Ltd.